Developer docs
API playgroundTry for free, no card

Search company profiles

OTV

Full company profile

uuid00024gd

Namestring
OTV
Legal namestring
Olive Tree Ventures
Websiteurl
otv.vc
Company typeenum
Private
Founded yearint
2019
Descriptiontext

OTV is a digital health venture capital fund, formerly Olive Tree Ventures, with offices in Tel Aviv, Israel and New York, USA. Founded by partners who have been working together since 2014 and who collectively founded seven prior companies generating over $4 billion in exit value, OTV invests in mid-growth stage digital health startups at Series A or later. The firm closed its first dedicated fund of $170 million in March 2021 and manages a portfolio of approximately 12 companies spanning telehealth (TytoCare, Lemonaid Health), AI-driven genomics interpretation (Emedgene), digital microscopy and AI-enabled cell morphology (Scopio Labs), objective pain monitoring (Medasense NOL), contact-free cardiopulmonary monitoring (Donisi Health), GI services (Hygieacare), driver/in-cabin monitoring (CU-BX), surgical fixation devices (Via Surgical), AR/VR collaboration (Campfire), and smart glass materials (Gauzy).

The fund's core value proposition is hands-on operating expertise combined with a curated network of multinational corporations, leading hospitals across the US/Europe/Asia, and global medical device companies that portfolio companies can leverage for clinical validation, regulatory clearance, and market access. Multiple portfolio companies have secured tier-one strategic partnerships — Siemens Healthineers for global distribution of Scopio's X100/X100HT, Beckman Coulter for hematology workcell integration, LG Electronics for T-OLED displays, and Illumina's Center of Excellence in Israel — and have achieved FDA De Novo clearances (Scopio FF-BMA, Medasense NOL/PMD-200) plus ANVISA approval in Brazil. Portfolio exits have been material: Lemonaid Health was acquired by 23andMe (announced July 2023), Emedgene was acquired by Illumina, and Gauzy filed a Form F-1 for an IPO in May 2024.

OTV's revenue model is standard for a venture fund: management fees on committed capital (and later on net invested capital) plus carried interest, typically 20%, on profits from successful portfolio exits. The firm markets to limited partners through a transparency-first approach — quarterly reports, regular updates, and an annual investor summit in Israel — and sources new investments primarily through founder referrals, existing portfolio CEO recommendations, and partnerships with accelerators, universities, and incubators where partners serve as mentors.

Short descriptiontext

OTV is a Tel Aviv- and New York-based digital health venture capital fund investing in mid-growth stage startups at Series A or later, backed by partners who previously founded seven companies generating over $4 billion in exits.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersTel Aviv, Israel
HQ citystring
Tel Aviv
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital health investing, venture capital fund, healthcare innovation, growth stage investments, digital health portfolio
NAICS code2 codes
  • Open-End Investment Funds525910
  • Funds, Trusts, and Other Financial Vehicles525
SIC code2 codes
  • Finance Services6199
  • Security & Commodity Brokers, Dealers, Exchanges & Services6200
Product category
Venture Capital - Digital Health
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Fund Management Fees and Carried Interest
TypeLicensing Royalties
Description

As a venture capital fund, OTV generates returns through management fees on committed capital and carried interest (typically 20%) on profits from successful portfolio company exits.

otv.vc
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Infrastructure, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

OTV is a digital health venture capital fund that invests capital in mid-growth stage digital health startups (Series A or later) and pairs that capital with strategic guidance, operational support, and introductions to multinational corporations, leading hospitals, and global medical device companies. The firm closed its first dedicated fund of $170 million in March 2021 and manages roughly 12 portfolio companies spanning telehealth, AI diagnostics, genomics, digital microscopy, surgical devices, and AI-driven patient monitoring.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Over $4 billion in shareholder value generated by founding 7 successful companies before becoming VC
+2 more records
Product overview1 text field

OTV is a venture capital firm (formerly Olive Tree Ventures) that invests in mid-growth stage digital health startups. The firm does not itself produce products but manages a portfolio of 12+ digital health portfolio companies. The portfolio includes TytoCare (handheld telehealth exam kit), Lemonaid Health (telehealth platform, now part of 23andMe), CU-BX (driver health monitoring), Donisi Health (contact-free cardiopulmonary monitoring), Emedgene (AI genomics interpretation, now part of Illumina), HyGIeaCare (GI/colonoscopy prep services), Medasense NOL (AI-powered pain monitoring), Scopio Labs (digital microscopy), Via Surgical (soft tissue fixation devices), and Campfire (AR/VR collaboration). OTV provides funding, strategic guidance, and industry connections to these digital health ventures.

Product and service3 records
1OTV Digital Health Venture Fund
CategoryVenture Capital Fund
2Portfolio Company Advisory and Operational Support
CategoryVenture Advisory Services
3LP Investor Reporting and Summit Program
CategoryInvestor Relations Services
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2024-05-20
Description

Gauzy and LG Electronics ID Division executed a memorandum of understanding to extend collaboration in advancing Transparent Organic Light Emitting Diode (T-OLED) displays using Gauzy's patented Suspended Particle Device technology.

2Beckman Coulter
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2023-11-06
Description

Beckman Coulter, a global leader in clinical diagnostics, partnered with Scopio Labs worldwide to accelerate adoption of digital cell morphology platform. Beckman Coulter connects Scopio Labs' digital morphology with hematology workcell for end-to-end digitization.

otv.vc
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2023-05-28
Description

Siemens Healthineers was granted global rights to distribute Scopio X100 and X100HT digital solutions featuring full-field imaging and AI-powered Decision Support System with remote viewing capabilities.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Emedgene (now an Illumina Company) partnership to automate interpretation of rare genetic disease data into Illumina's TruSight software suite. Illumina also established Center of Excellence in Israel focusing on AI-driven interpretation technology.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Safety Tech (a Gauzy company) partners with LUMINATOR TECHNOLOGY GROUP to bring mirrorless driver assistance systems to mass transit bus market. Safety Tech's Camera Monitor System is already chosen by over 40 operators and multiple bus/coach/truck OEMs.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

OTV partners with multinational corporations, leading hospitals in US/Europe/Asia, global medical device companies, and multinational digital companies for portfolio companies' product definition, clinical validation, and market access.

Strategic tierCoreTypeTechnology or Integration
Description

Gauzy licensed Research Frontiers' patented SPD-SmartGlass light-control technology. Following $60M Series D financing, Gauzy acquired Research Frontiers licensee Vision Systems, becoming the largest internationally diversified smart glass technologies company.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Large multi-stage venture firm with a dedicated bio/health fund investing across digital health, biotech, and healthcare services. Directly comparable to OTV as a digital health investor with deep networks and operator partners, though significantly larger in AUM and team size.

TypeBroad incumbent
Description

Multi-stage venture firm with a significant healthcare practice spanning digital health, healthcare services, and healthtech infrastructure. Comparable to OTV as a digital health investor with operator-led thesis and global LP base, but at materially larger fund size.

TypeBroad incumbent
Description

Long-tenured venture firm with a dedicated healthcare practice investing across digital health, biotech, and healthcare services. Comparable to OTV as a multi-stage digital health investor with global presence, though with a much larger and more diversified fund portfolio.

TypeBroad incumbent
Description

Multi-stage venture firm with a substantial healthcare and digital health practice investing from seed through growth. Comparable to OTV as an operator-driven digital health investor, though with significantly broader sector coverage and larger fund vintages.

TypeBroad incumbent
Description

One of the largest venture firms globally with a deep healthcare practice spanning digital health, medical devices, and biotech. Comparable to OTV as a digital health investor with multi-stage deployment, though with a much larger team and longer track record.

TypeDirect peer
Description

Early-to-growth stage venture firm exclusively focused on digital health, led by operator-investors. One of the closest direct peers to OTV in digital health-only thesis, fund size, and stage focus, though based in San Francisco rather than Israel/NY.

TypeDirect peer
Description

Digital health-focused venture firm founded by Bill Maris (ex-Google Ventures) investing in growth-stage healthcare and biotech companies. Closely comparable to OTV as a digital health-focused growth investor with operator-GP branding.

TypeDirect peer
Description

Specialist venture and growth equity firm exclusively focused on healthcare services and financial technology. Highly comparable to OTV as a thesis-driven, sector-focused investor, though typically deploying larger growth-stage checks.

TypeDirect peer
Description

Early-stage venture firm exclusively focused on digital health, investing across Series A and B in health tech, tech-enabled services, and digital therapeutics. Comparable to OTV as a digital health-focused specialist, though earlier-stage focused with a smaller fund size.

TypeBroad incumbent
Description

Multi-stage venture firm with a meaningful healthcare and biotech portfolio, known for founder-led investing. Comparable to OTV's operator-GP thesis and high-conviction digital health bets, though OTV is more sector-concentrated.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment17 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

OTV

Venture Capital - Digital Healthotv.vc

OTV is a Tel Aviv- and New York-based digital health venture capital fund investing in mid-growth stage startups at Series A or later, backed by partners who previously founded seven companies generating over $4 billion in exits.

What OTV does

OTV is a digital health venture capital fund, formerly Olive Tree Ventures, with offices in Tel Aviv, Israel and New York, USA. Founded by partners who have been working together since 2014 and who collectively founded seven prior companies generating over $4 billion in exit value, OTV invests in mid-growth stage digital health startups at Series A or later. The firm closed its first dedicated fund of $170 million in March 2021 and manages a portfolio of approximately 12 companies spanning telehealth (TytoCare, Lemonaid Health), AI-driven genomics interpretation (Emedgene), digital microscopy and AI-enabled cell morphology (Scopio Labs), objective pain monitoring (Medasense NOL), contact-free cardiopulmonary monitoring (Donisi Health), GI services (Hygieacare), driver/in-cabin monitoring (CU-BX), surgical fixation devices (Via Surgical), AR/VR collaboration (Campfire), and smart glass materials (Gauzy).

The fund's core value proposition is hands-on operating expertise combined with a curated network of multinational corporations, leading hospitals across the US/Europe/Asia, and global medical device companies that portfolio companies can leverage for clinical validation, regulatory clearance, and market access. Multiple portfolio companies have secured tier-one strategic partnerships — Siemens Healthineers for global distribution of Scopio's X100/X100HT, Beckman Coulter for hematology workcell integration, LG Electronics for T-OLED displays, and Illumina's Center of Excellence in Israel — and have achieved FDA De Novo clearances (Scopio FF-BMA, Medasense NOL/PMD-200) plus ANVISA approval in Brazil. Portfolio exits have been material: Lemonaid Health was acquired by 23andMe (announced July 2023), Emedgene was acquired by Illumina, and Gauzy filed a Form F-1 for an IPO in May 2024.

OTV's revenue model is standard for a venture fund: management fees on committed capital (and later on net invested capital) plus carried interest, typically 20%, on profits from successful portfolio exits. The firm markets to limited partners through a transparency-first approach — quarterly reports, regular updates, and an annual investor summit in Israel — and sources new investments primarily through founder referrals, existing portfolio CEO recommendations, and partnerships with accelerators, universities, and incubators where partners serve as mentors.

OTV firmographics

Firmographics
Name
OTV
Legal name
Olive Tree Ventures
Website
https://otv.vc
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
11–50 employees
Short description
OTV is a Tel Aviv- and New York-based digital health venture capital fund investing in mid-growth stage startups at Series A or later, backed by partners who previously founded seven companies generating over $4 billion in exits.
Ownership category
akta.pro rank

Where OTV is headquartered

Location

Headquarters

HQ city
Tel Aviv
HQ country
Israel
HQ region
Middle East

Offices2 records

Markets served

OTV business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Infrastructure, Others

Revenue model

  1. Fund Management Fees and Carried Interest: As a venture capital fund, OTV generates returns through management fees on committed capital and carried interest (typically 20%) on profits from successful portfolio company exits.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

OTV product offering

Product offering

Core offering

OTV is a digital health venture capital fund that invests capital in mid-growth stage digital health startups (Series A or later) and pairs that capital with strategic guidance, operational support, and introductions to multinational corporations, leading hospitals, and global medical device companies. The firm closed its first dedicated fund of $170 million in March 2021 and manages roughly 12 portfolio companies spanning telehealth, AI diagnostics, genomics, digital microscopy, surgical devices, and AI-driven patient monitoring.

Product overview

OTV is a venture capital firm (formerly Olive Tree Ventures) that invests in mid-growth stage digital health startups. The firm does not itself produce products but manages a portfolio of 12+ digital health portfolio companies. The portfolio includes TytoCare (handheld telehealth exam kit), Lemonaid Health (telehealth platform, now part of 23andMe), CU-BX (driver health monitoring), Donisi Health (contact-free cardiopulmonary monitoring), Emedgene (AI genomics interpretation, now part of Illumina), HyGIeaCare (GI/colonoscopy prep services), Medasense NOL (AI-powered pain monitoring), Scopio Labs (digital microscopy), Via Surgical (soft tissue fixation devices), and Campfire (AR/VR collaboration). OTV provides funding, strategic guidance, and industry connections to these digital health ventures.

Differentiator

Problem solved

Functional benefit

Products and services

  • OTV Digital Health Venture Fund
  • Portfolio Company Advisory and Operational Support
  • LP Investor Reporting and Summit Program

Quantifiable outcome

  • Over $4 billion in shareholder value generated by founding 7 successful companies before becoming VC
  • +2 more outcomes

Companies that use OTV

Customer profile

Named customers8 records

Segments2 records

Ideal customer profiles2 records

OTV technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability9 records

OTV partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered flagship, core and minor.

  • LG ElectronicsflagshipStrategic or Co-development Partner · 20 May 2024Gauzy and LG Electronics ID Division executed a memorandum of understanding to extend collaboration in advancing Transparent Organic Light Emitting Diode (T-OLED) displays using Gauzy's patented Suspended Particle Device technology.
  • Beckman CoultercoreChannel Partner/ Reseller/ Distributor · 6 November 2023Beckman Coulter, a global leader in clinical diagnostics, partnered with Scopio Labs worldwide to accelerate adoption of digital cell morphology platform. Beckman Coulter connects Scopio Labs' digital morphology with hematology workcell for end-to-end digitization.
  • Siemens HealthineerscoreChannel Partner/ Reseller/ Distributor · 28 May 2023Siemens Healthineers was granted global rights to distribute Scopio X100 and X100HT digital solutions featuring full-field imaging and AI-powered Decision Support System with remote viewing capabilities.
  • IlluminacoreStrategic or Co-development PartnerEmedgene (now an Illumina Company) partnership to automate interpretation of rare genetic disease data into Illumina's TruSight software suite. Illumina also established Center of Excellence in Israel focusing on AI-driven interpretation technology.
  • Safety TechminorChannel Partner/ Reseller/ DistributorSafety Tech (a Gauzy company) partners with LUMINATOR TECHNOLOGY GROUP to bring mirrorless driver assistance systems to mass transit bus market. Safety Tech's Camera Monitor System is already chosen by over 40 operators and multiple bus/coach/truck OEMs.
  • Multinational Corporations and HospitalscoreStrategic or Co-development PartnerOTV partners with multinational corporations, leading hospitals in US/Europe/Asia, global medical device companies, and multinational digital companies for portfolio companies' product definition, clinical validation, and market access.
  • Research FrontierscoreTechnology or IntegrationGauzy licensed Research Frontiers' patented SPD-SmartGlass light-control technology. Following $60M Series D financing, Gauzy acquired Research Frontiers licensee Vision Systems, becoming the largest internationally diversified smart glass technologies company.

Scale indicators5 records

Recent moves7 records

Expansion highlights4 records

OTV competitors and assessment

Company assessment

Broad incumbents

  • Andreessen Horowitz (a16z Bio): Large multi-stage venture firm with a dedicated bio/health fund investing across digital health, biotech, and healthcare services. Directly comparable to OTV as a digital health investor with deep networks and operator partners, though significantly larger in AUM and team size.
  • General Catalyst: Multi-stage venture firm with a significant healthcare practice spanning digital health, healthcare services, and healthtech infrastructure. Comparable to OTV as a digital health investor with operator-led thesis and global LP base, but at materially larger fund size.
  • Bessemer Venture Partners: Long-tenured venture firm with a dedicated healthcare practice investing across digital health, biotech, and healthcare services. Comparable to OTV as a multi-stage digital health investor with global presence, though with a much larger and more diversified fund portfolio.
  • Khosla Ventures: Multi-stage venture firm with a substantial healthcare and digital health practice investing from seed through growth. Comparable to OTV as an operator-driven digital health investor, though with significantly broader sector coverage and larger fund vintages.
  • New Enterprise Associates (NEA): One of the largest venture firms globally with a deep healthcare practice spanning digital health, medical devices, and biotech. Comparable to OTV as a digital health investor with multi-stage deployment, though with a much larger team and longer track record.
  • Founders Fund: Multi-stage venture firm with a meaningful healthcare and biotech portfolio, known for founder-led investing. Comparable to OTV's operator-GP thesis and high-conviction digital health bets, though OTV is more sector-concentrated.

Direct peers

  • Define Ventures: Early-to-growth stage venture firm exclusively focused on digital health, led by operator-investors. One of the closest direct peers to OTV in digital health-only thesis, fund size, and stage focus, though based in San Francisco rather than Israel/NY.
  • Section 32: Digital health-focused venture firm founded by Bill Maris (ex-Google Ventures) investing in growth-stage healthcare and biotech companies. Closely comparable to OTV as a digital health-focused growth investor with operator-GP branding.
  • Oak HC/FT: Specialist venture and growth equity firm exclusively focused on healthcare services and financial technology. Highly comparable to OTV as a thesis-driven, sector-focused investor, though typically deploying larger growth-stage checks.
  • Flare Capital Partners: Early-stage venture firm exclusively focused on digital health, investing across Series A and B in health tech, tech-enabled services, and digital therapeutics. Comparable to OTV as a digital health-focused specialist, though earlier-stage focused with a smaller fund size.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

OTV social profiles

Digital presence

OTV financial estimates

Financial estimate

Revenue estimate

Valuation estimate

OTV leadership team

Management profile

Number of profiles

Profiles5 records

OTV funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

OTV M&A and investment

M&A and investment

M&A

Investments17 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OTV

What does OTV do?

OTV is a digital health venture capital fund that invests capital in mid-growth stage digital health startups (Series A or later) and pairs that capital with strategic guidance, operational support, and introductions to multinational corporations, leading hospitals, and global medical device companies. The firm closed its first dedicated fund of $170 million in March 2021 and manages roughly 12 portfolio companies spanning telehealth, AI diagnostics, genomics, digital microscopy, surgical devices, and AI-driven patient monitoring.

Is OTV a public or private company?

OTV is a private company. It is classified as management employee owned and is currently operating.

When was OTV founded?

OTV was founded in 2019. It employs 11 to 50 people.

Where is OTV based?

OTV is headquartered in Tel Aviv, Israel, in the Middle East region.

How does OTV make money?

One revenue line is on record: fund Management Fees and Carried Interest.

Who are OTV's main competitors?

Broad incumbents on record are Andreessen Horowitz (a16z Bio), General Catalyst, Bessemer Venture Partners, Khosla Ventures, New Enterprise Associates (NEA) and Founders Fund. Direct peers are Define Ventures, Section 32, Oak HC/FT and Flare Capital Partners.

Does OTV have an API?

No public API is recorded for OTV.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
NextTVCuriosity Strikes Carriage Deal With FuboTVCuriosity Inc. announced a multi-year carriage agreement with fuboTV for its linear Curiosity Channel and Curiosity Stream VOD in the U.S. and Canada. The linear channel will be available to fuboTV's Extra package, which includes about 40 channels. The deal follows Curiosity's Q2 subscriber growth to about 20 million.IFTTTOTV closes $170m Israel digital health VC fundOTV closed a $170 million venture capital fund for Israeli digital health startups, aiming to help portfolio companies reach maturity and tackle regulatory hurdles. The fund follows five years of focus on digital health, with past investments in TytoCare, Lemonaid Health, and others. OTV also appointed Jose Antonio Urrutia Rivas as head of Asia Pacific.PR NewswireOTV Announces Close of $170M Venture Fund for Digital Health GrowthOTV (formerly Olive Tree Ventures), Israel's only digital health-focused venture capital firm, announced the closing of a $170 million fund, along with a rebranding from its original name and the appointment of Jose Antonio Urrutia Rivas as Head of Asia Pacific. The firm also revealed plans to open a new Asia Pacific office in China, complementing existing locations in New York, Tel Aviv, and Montreal, to support portfolio companies' expansion into the region. The announcement reflects growing investor interest in digital health solutions amid strained global healthcare systems.TechCrunchHealth tech venture firm OTV closes new $170 million fund and expands into AsiaIsraeli venture capital firm OTV (formerly Olive Tree Ventures) announced the close of a $170 million fund and the opening of a new office in Shanghai, China, marking its expansion into the Asia Pacific region. The firm, which currently has 11 companies in its portfolio, has been leading investment rounds in digital health companies including TytoCare, Lemonaid Health, Emedgene, Scopio, and Donisi Health, and plans to focus on helping B and C round companies navigate regulations during expansion. OTV has appointed Jose Antonio Urrutia Rivas as head of Asia Pacific, bringing the firm's total offices to four alongside New York, Tel Aviv, and Montreal.CTechTyto Care Wants to Be Your Doctor’s Eyes and HandsTyto Care, an Israel-based company, developed a handheld device for remote medical diagnosis from home, with data sent to doctors. The company raised $50 million in a round led by Olive Tree Ventures, Insight Partners, and Qualcomm Ventures. It plans to launch a next-generation device and add respiratory and throat diagnostics later this year.PR NewswireTyto Care Raises $50M to Expand Its Telehealth Exam and Diagnosis Offering GloballyTyto Care, a telehealth company offering remote medical examination devices and platform services, raised $50 million in an oversubscribed funding round co-led by Insight Partners, Olive Tree Ventures, and Qualcomm Ventures LLC, bringing total funding to over $105 million. The company reported threefold sales growth in 2019 and double-digit telehealth utilization rates exceeding 10 times the industry average of under 5%. The funding will support global commercialization across the U.S., Europe, and Asia, as well as development of AI and machine learning-based home diagnostics solutions, as hospitals worldwide expand use of the platform to remotely examine COVID-19 patients.MobiHealthNewsGenetic data interpretation startup raises $6MEmedgene, an Israeli startup using artificial intelligence to interpret genetic data for clinicians, closed a $6 million round led by OliveTree Ventures. The company said the funds will expand its US sales operations. Its platform is used by Israel's MoH 100K Genome Project and dozens of other global customers.